Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Franco Rongioletti and Luca Stingeni.
Franco Rongioletti
Connection Strength
0.510
Luca Stingeni
  1. Efficacy and safety of adalimumab after failure of other anti-TNFa agents for plaque-type psoriasis: clinician behavior in real life clinical practice. J Dermatolog Treat. 2019 Aug; 30(5):441-445.
    View in: PubMed
    Score: 0.198
  2. Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry. Allergy. 2021 06; 76(6):1813-1824.
    View in: PubMed
    Score: 0.058
  3. Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study. Expert Opin Biol Ther. 2021 02; 21(2):271-277.
    View in: PubMed
    Score: 0.058
  4. Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy. J Eur Acad Dermatol Venereol. 2020 Dec; 34(12):e770-e772.
    View in: PubMed
    Score: 0.056
  5. HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2019 Apr; 33(4):766-773.
    View in: PubMed
    Score: 0.051
  6. An Italian multicentre study on adult atopic dermatitis: persistent versus adult-onset disease. Arch Dermatol Res. 2017 Aug; 309(6):443-452.
    View in: PubMed
    Score: 0.045
  7. Italian guidelines on the systemic treatments of moderate-to-severe plaque psoriasis. J Eur Acad Dermatol Venereol. 2017 May; 31(5):774-790.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.